EquityGlobal - OtherVery High Risk
Direct
NAV (26-Mar-25)
Returns (Since Inception)
Fund Size
₹3,249 Cr
Expense Ratio
1.25%
ISIN
INF109K01Z71
Minimum SIP
₹1,000
Exit Load
1.00%
Inception Date
02 Jan 2013
In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
1 Year
+4.15%
— (Cat Avg.)
3 Years
+10.10%
— (Cat Avg.)
5 Years
+16.97%
— (Cat Avg.)
10 Years
+14.29%
— (Cat Avg.)
Since Inception
+15.96%
— (Cat Avg.)
Equity | ₹3,186.39 Cr | 98.08% |
Others | ₹62.52 Cr | 1.92% |
All Holdings
Equity
Debt & Others
Name | Type | Amount | Holdings |
---|---|---|---|
Gilead Sciences Inc | Equity | ₹103.63 Cr | 3.19% |
Altria Group Inc | Equity | ₹94.64 Cr | 2.91% |
The Walt Disney Co | Equity | ₹92.44 Cr | 2.85% |
Bristol-Myers Squibb Co | Equity | ₹91.04 Cr | 2.80% |
Corteva Inc | Equity | ₹90.74 Cr | 2.79% |
Kenvue Inc | Equity | ₹87.26 Cr | 2.69% |
Boeing Co | Equity | ₹81.78 Cr | 2.52% |
Brown-Forman Corp Registered Shs -B- Non Vtg | Equity | ₹81.49 Cr | 2.51% |
The Campbell`s Co | Equity | ₹80.54 Cr | 2.48% |
Veeva Systems Inc Class A | Equity | ₹80.28 Cr | 2.47% |
U.S. Bancorp | Equity | ₹79.53 Cr | 2.45% |
Pfizer Inc | Equity | ₹78.07 Cr | 2.40% |
Microchip Technology Inc | Equity | ₹77.69 Cr | 2.39% |
Zimmer Biomet Holdings Inc | Equity | ₹77.5 Cr | 2.39% |
Nike Inc Class B | Equity | ₹77.46 Cr | 2.38% |
Huntington Ingalls Industries Inc | Equity | ₹73.95 Cr | 2.28% |
NXP Semiconductors NV | Equity | ₹73.11 Cr | 2.25% |
The Estee Lauder Companies Inc Class A | Equity | ₹72.51 Cr | 2.23% |
Adobe Inc | Equity | ₹71.86 Cr | 2.21% |
Agilent Technologies Inc | Equity | ₹69.91 Cr | 2.15% |
International Flavors & Fragrances Inc | Equity | ₹68.99 Cr | 2.12% |
Allegion PLC | Equity | ₹68.61 Cr | 2.11% |
Etsy Inc | Equity | ₹67.9 Cr | 2.09% |
TransUnion | Equity | ₹67.69 Cr | 2.08% |
United Parcel Service Inc Class B | Equity | ₹67.21 Cr | 2.07% |
Bio-Rad Laboratories Inc Class A | Equity | ₹65.62 Cr | 2.02% |
Medtronic PLC | Equity | ₹65.58 Cr | 2.02% |
MarketAxess Holdings Inc | Equity | ₹63.84 Cr | 1.97% |
Comcast Corp Class A | Equity | ₹60.47 Cr | 1.86% |
Alphabet Inc Class C | Equity | ₹59.72 Cr | 1.84% |
Net Current Assets | Cash | ₹59.16 Cr | 1.82% |
Charles Schwab Corp | Equity | ₹56.36 Cr | 1.73% |
Amazon.com Inc | Equity | ₹49.26 Cr | 1.52% |
Amgen Inc | Equity | ₹45.77 Cr | 1.41% |
Equifax Inc | Equity | ₹42.41 Cr | 1.31% |
Mondelez International Inc Class A | Equity | ₹42.1 Cr | 1.30% |
Honeywell International Inc | Equity | ₹42 Cr | 1.29% |
Microsoft Corp | Equity | ₹38.5 Cr | 1.19% |
Northrop Grumman Corp | Equity | ₹37.37 Cr | 1.15% |
Thermo Fisher Scientific Inc | Equity | ₹36.62 Cr | 1.13% |
Danaher Corp | Equity | ₹36.32 Cr | 1.12% |
Lam Research Corp | Equity | ₹36.03 Cr | 1.11% |
Merck & Co Inc | Equity | ₹34.67 Cr | 1.07% |
Biogen Inc | Equity | ₹32.36 Cr | 1.00% |
Constellation Brands Inc Class A | Equity | ₹30.68 Cr | 0.94% |
Teradyne Inc | Equity | ₹30.45 Cr | 0.94% |
Autodesk Inc | Equity | ₹30.14 Cr | 0.93% |
Masco Corp | Equity | ₹29.87 Cr | 0.92% |
Monolithic Power Systems Inc | Equity | ₹28.71 Cr | 0.88% |
West Pharmaceutical Services Inc | Equity | ₹28.43 Cr | 0.88% |
Occidental Petroleum Corp | Equity | ₹20.4 Cr | 0.63% |
EPAM Systems Inc | Equity | ₹20.13 Cr | 0.62% |
Otis Worldwide Corp Ordinary Shares | Equity | ₹17.96 Cr | 0.55% |
IDEX Corp | Equity | ₹17.56 Cr | 0.54% |
Emerson Electric Co | Equity | ₹16.96 Cr | 0.52% |
Cognizant Technology Solutions Corp Class A | Equity | ₹16.17 Cr | 0.50% |
Salesforce Inc | Equity | ₹16 Cr | 0.49% |
Freeport-McMoRan Inc | Equity | ₹15.91 Cr | 0.49% |
Globant SA | Equity | ₹13.77 Cr | 0.42% |
ASML Holding NV ADR | Equity | ₹9.92 Cr | 0.31% |
Qualcomm Inc | Equity | ₹8.74 Cr | 0.27% |
Clorox Co | Equity | ₹8.26 Cr | 0.25% |
Newmont Corp | Equity | ₹5.47 Cr | 0.17% |
Treps | Cash - Repurchase Agreement | ₹3.36 Cr | 0.10% |
Equity Sector
Debt & Others
Sector | Amount | Holdings |
---|---|---|
Healthcare | ₹845.8 Cr | 26.03% |
Consumer Defensive | ₹497.49 Cr | 15.31% |
Industrials | ₹495.69 Cr | 15.26% |
Technology | ₹471.22 Cr | 14.50% |
Financial Services | ₹267.42 Cr | 8.23% |
Communication Services | ₹212.63 Cr | 6.54% |
Consumer Cyclical | ₹194.62 Cr | 5.99% |
Basic Materials | ₹181.11 Cr | 5.57% |
Energy | ₹20.4 Cr | 0.63% |
Standard Deviation
This fund
18.39%
Cat. avg.
--
Lower the better
Sharpe Ratio
This fund
0.40
Cat. avg.
--
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
--
Higher the better
Since September 2024
Since July 2022
Since November 2024
ISIN INF109K01Z71 | Expense Ratio 1.25% | Exit Load 1.00% | Fund Size ₹3,249 Cr | Age 12 years 2 months | Lumpsum Minimum ₹5,000 | Fund Status Open Ended Investment Company | Benchmark S&P 500 TR USD |
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.
Fund name | Expense Ratio | Exit Load | Fund size | 1Y |
---|---|---|---|---|
Aditya Birla Sun Life Commodity Equity Global Agricultural Regular Growth Very High Risk | 1.7% | 1.0% | ₹13.04 Cr | -3.0% |
HSBC Asia Pacific (Ex Japan) Dividend Yield Fund Regular Growth Very High Risk | 1.9% | 1.0% | ₹8.25 Cr | 12.5% |
HSBC Asia Pacific (Ex Japan) Dividend Yield Fund Direct Growth Very High Risk | 1.6% | 1.0% | ₹8.25 Cr | 12.9% |
Franklin Asian Equity Fund Regular Growth Very High Risk | 2.5% | 1.0% | ₹239.90 Cr | 10.9% |
DSP Global Innovation Fund of Fund Direct Growth Very High Risk | 0.4% | 0.0% | ₹966.95 Cr | 10.3% |
DSP Global Innovation Fund of Fund Regular Growth Very High Risk | 1.3% | 0.0% | ₹966.95 Cr | 9.3% |
Aditya Birla Sun Life Global Emerging Opportunities Fund Regular Growth Very High Risk | 2.1% | 0.0% | ₹255.64 Cr | 4.6% |
Edelweiss US Value Equity Offshore Fund Regular Growth Very High Risk | 2.3% | 1.0% | ₹180.66 Cr | 10.7% |
Edelweiss US Value Equity Offshore Fund Direct Growth Very High Risk | 1.4% | 1.0% | ₹180.66 Cr | 11.7% |
ICICI Prudential Global Advantage Fund (FOF) Regular Growth Very High Risk | 2.6% | 1.0% | ₹340.36 Cr | 21.5% |
Total AUM
₹9,02,856 Cr
Address
3rd Floor, Hallmark Business Plaza, Mumbai, 400 051
Your principal amount will be at Very High Risk
EquityGlobal - OtherVery High Risk
Direct
NAV (26-Mar-25)
Returns (Since Inception)
Fund Size
₹3,249 Cr
Expense Ratio
1.25%
ISIN
INF109K01Z71
Minimum SIP
₹1,000
Exit Load
1.00%
Inception Date
02 Jan 2013
Your principal amount will be at Very High Risk
In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
1 Year
+4.15%
— (Cat Avg.)
3 Years
+10.10%
— (Cat Avg.)
5 Years
+16.97%
— (Cat Avg.)
10 Years
+14.29%
— (Cat Avg.)
Since Inception
+15.96%
— (Cat Avg.)
Equity | ₹3,186.39 Cr | 98.08% |
Others | ₹62.52 Cr | 1.92% |
All Holdings
Equity
Debt & Others
Name | Type | Amount | Holdings |
---|---|---|---|
Gilead Sciences Inc | Equity | ₹103.63 Cr | 3.19% |
Altria Group Inc | Equity | ₹94.64 Cr | 2.91% |
The Walt Disney Co | Equity | ₹92.44 Cr | 2.85% |
Bristol-Myers Squibb Co | Equity | ₹91.04 Cr | 2.80% |
Corteva Inc | Equity | ₹90.74 Cr | 2.79% |
Kenvue Inc | Equity | ₹87.26 Cr | 2.69% |
Boeing Co | Equity | ₹81.78 Cr | 2.52% |
Brown-Forman Corp Registered Shs -B- Non Vtg | Equity | ₹81.49 Cr | 2.51% |
The Campbell`s Co | Equity | ₹80.54 Cr | 2.48% |
Veeva Systems Inc Class A | Equity | ₹80.28 Cr | 2.47% |
U.S. Bancorp | Equity | ₹79.53 Cr | 2.45% |
Pfizer Inc | Equity | ₹78.07 Cr | 2.40% |
Microchip Technology Inc | Equity | ₹77.69 Cr | 2.39% |
Zimmer Biomet Holdings Inc | Equity | ₹77.5 Cr | 2.39% |
Nike Inc Class B | Equity | ₹77.46 Cr | 2.38% |
Huntington Ingalls Industries Inc | Equity | ₹73.95 Cr | 2.28% |
NXP Semiconductors NV | Equity | ₹73.11 Cr | 2.25% |
The Estee Lauder Companies Inc Class A | Equity | ₹72.51 Cr | 2.23% |
Adobe Inc | Equity | ₹71.86 Cr | 2.21% |
Agilent Technologies Inc | Equity | ₹69.91 Cr | 2.15% |
International Flavors & Fragrances Inc | Equity | ₹68.99 Cr | 2.12% |
Allegion PLC | Equity | ₹68.61 Cr | 2.11% |
Etsy Inc | Equity | ₹67.9 Cr | 2.09% |
TransUnion | Equity | ₹67.69 Cr | 2.08% |
United Parcel Service Inc Class B | Equity | ₹67.21 Cr | 2.07% |
Bio-Rad Laboratories Inc Class A | Equity | ₹65.62 Cr | 2.02% |
Medtronic PLC | Equity | ₹65.58 Cr | 2.02% |
MarketAxess Holdings Inc | Equity | ₹63.84 Cr | 1.97% |
Comcast Corp Class A | Equity | ₹60.47 Cr | 1.86% |
Alphabet Inc Class C | Equity | ₹59.72 Cr | 1.84% |
Net Current Assets | Cash | ₹59.16 Cr | 1.82% |
Charles Schwab Corp | Equity | ₹56.36 Cr | 1.73% |
Amazon.com Inc | Equity | ₹49.26 Cr | 1.52% |
Amgen Inc | Equity | ₹45.77 Cr | 1.41% |
Equifax Inc | Equity | ₹42.41 Cr | 1.31% |
Mondelez International Inc Class A | Equity | ₹42.1 Cr | 1.30% |
Honeywell International Inc | Equity | ₹42 Cr | 1.29% |
Microsoft Corp | Equity | ₹38.5 Cr | 1.19% |
Northrop Grumman Corp | Equity | ₹37.37 Cr | 1.15% |
Thermo Fisher Scientific Inc | Equity | ₹36.62 Cr | 1.13% |
Danaher Corp | Equity | ₹36.32 Cr | 1.12% |
Lam Research Corp | Equity | ₹36.03 Cr | 1.11% |
Merck & Co Inc | Equity | ₹34.67 Cr | 1.07% |
Biogen Inc | Equity | ₹32.36 Cr | 1.00% |
Constellation Brands Inc Class A | Equity | ₹30.68 Cr | 0.94% |
Teradyne Inc | Equity | ₹30.45 Cr | 0.94% |
Autodesk Inc | Equity | ₹30.14 Cr | 0.93% |
Masco Corp | Equity | ₹29.87 Cr | 0.92% |
Monolithic Power Systems Inc | Equity | ₹28.71 Cr | 0.88% |
West Pharmaceutical Services Inc | Equity | ₹28.43 Cr | 0.88% |
Occidental Petroleum Corp | Equity | ₹20.4 Cr | 0.63% |
EPAM Systems Inc | Equity | ₹20.13 Cr | 0.62% |
Otis Worldwide Corp Ordinary Shares | Equity | ₹17.96 Cr | 0.55% |
IDEX Corp | Equity | ₹17.56 Cr | 0.54% |
Emerson Electric Co | Equity | ₹16.96 Cr | 0.52% |
Cognizant Technology Solutions Corp Class A | Equity | ₹16.17 Cr | 0.50% |
Salesforce Inc | Equity | ₹16 Cr | 0.49% |
Freeport-McMoRan Inc | Equity | ₹15.91 Cr | 0.49% |
Globant SA | Equity | ₹13.77 Cr | 0.42% |
ASML Holding NV ADR | Equity | ₹9.92 Cr | 0.31% |
Qualcomm Inc | Equity | ₹8.74 Cr | 0.27% |
Clorox Co | Equity | ₹8.26 Cr | 0.25% |
Newmont Corp | Equity | ₹5.47 Cr | 0.17% |
Treps | Cash - Repurchase Agreement | ₹3.36 Cr | 0.10% |
Equity Sector
Debt & Others
Sector | Amount | Holdings |
---|---|---|
Healthcare | ₹845.8 Cr | 26.03% |
Consumer Defensive | ₹497.49 Cr | 15.31% |
Industrials | ₹495.69 Cr | 15.26% |
Technology | ₹471.22 Cr | 14.50% |
Financial Services | ₹267.42 Cr | 8.23% |
Communication Services | ₹212.63 Cr | 6.54% |
Consumer Cyclical | ₹194.62 Cr | 5.99% |
Basic Materials | ₹181.11 Cr | 5.57% |
Energy | ₹20.4 Cr | 0.63% |
Standard Deviation
This fund
18.39%
Cat. avg.
--
Lower the better
Sharpe Ratio
This fund
0.40
Cat. avg.
--
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
--
Higher the better
Since September 2024
Since July 2022
Since November 2024
ISIN INF109K01Z71 | Expense Ratio 1.25% | Exit Load 1.00% | Fund Size ₹3,249 Cr | Age 12 years 2 months | Lumpsum Minimum ₹5,000 | Fund Status Open Ended Investment Company | Benchmark S&P 500 TR USD |
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.
Fund name | Expense Ratio | Exit Load | Fund size | 1Y |
---|---|---|---|---|
Aditya Birla Sun Life Commodity Equity Global Agricultural Regular Growth Very High Risk | 1.7% | 1.0% | ₹13.04 Cr | -3.0% |
HSBC Asia Pacific (Ex Japan) Dividend Yield Fund Regular Growth Very High Risk | 1.9% | 1.0% | ₹8.25 Cr | 12.5% |
HSBC Asia Pacific (Ex Japan) Dividend Yield Fund Direct Growth Very High Risk | 1.6% | 1.0% | ₹8.25 Cr | 12.9% |
Franklin Asian Equity Fund Regular Growth Very High Risk | 2.5% | 1.0% | ₹239.90 Cr | 10.9% |
DSP Global Innovation Fund of Fund Direct Growth Very High Risk | 0.4% | 0.0% | ₹966.95 Cr | 10.3% |
DSP Global Innovation Fund of Fund Regular Growth Very High Risk | 1.3% | 0.0% | ₹966.95 Cr | 9.3% |
Aditya Birla Sun Life Global Emerging Opportunities Fund Regular Growth Very High Risk | 2.1% | 0.0% | ₹255.64 Cr | 4.6% |
Edelweiss US Value Equity Offshore Fund Regular Growth Very High Risk | 2.3% | 1.0% | ₹180.66 Cr | 10.7% |
Edelweiss US Value Equity Offshore Fund Direct Growth Very High Risk | 1.4% | 1.0% | ₹180.66 Cr | 11.7% |
ICICI Prudential Global Advantage Fund (FOF) Regular Growth Very High Risk | 2.6% | 1.0% | ₹340.36 Cr | 21.5% |
Total AUM
₹9,02,856 Cr
Address
3rd Floor, Hallmark Business Plaza, Mumbai, 400 051
Get your portfolio reviewed by experts
Download Wealth Monitor App
Track and monitor all
your investments